MedTrace Logo

A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer

NCT01964170 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 234

Last updated 2024-10-31

No results posted yet for this study

Summary

To compare the efficacy and safety of ASP3550 to goserelin acetate in patients with prostate cancer.

Conditions

Interventions

DRUG

degarelix

subcutaneous

DRUG

Goserelin

subcutaneous

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Medical Director · Astellas Pharma Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-13
Primary Completion
2015-06-05
Completion
2016-08-08

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01964170 on ClinicalTrials.gov